BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33863658)

  • 21. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.
    Htun WW; Grines C; Schreiber T
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1339-1344. PubMed ID: 28988450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline global longitudinal strain by computed tomography is associated with post transcatheter aortic valve replacement outcomes.
    Fukui M; Xu J; Thoma F; Sultan I; Mulukutla S; Elzomor H; Lee JS; Gleason TG; Cavalcante JL
    J Cardiovasc Comput Tomogr; 2020; 14(3):233-239. PubMed ID: 31836414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.
    Puymirat E; Didier R; Eltchaninoff H; Lung B; Collet JP; Himbert D; Durand E; Leguerrier A; Leprince P; Fajadet J; Teiger E; Chevreul K; Lièvre M; Tchetché D; Leclercq F; Chassaing S; Le Breton H; Donzeau-Gouge P; Lefèvre T; Carrié D; Gillard M; Blanchard D
    Clin Cardiol; 2017 Dec; 40(12):1316-1322. PubMed ID: 29247516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.
    Tarantini G; Nai Fovino L; Le Prince P; Darremont O; Urena M; Bartorelli AL; Vincent F; Hovorka T; Alcalá Navarro Y; Dumonteil N; Ohlmann P; Wendler O
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008972. PubMed ID: 32580586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of Routine Invasive Coronary Angiography Prior to Transcatheter Aortic Valve Replacement.
    Case BC; Yerasi C; Forrestal BJ; Musallam A; Chezar-Azerrad C; Hahm J; Kumar S; Satler LF; Ben-Dor I; Hashim H; Waksman R; Rogers T
    Cardiovasc Revasc Med; 2021 May; 26():1-5. PubMed ID: 33246809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of Transcatheter Aortic Valve Replacement With Percutaneous Coronary Intervention versus Surgical Aortic Valve Replacement With Coronary Artery Bypass Grafting.
    Abugroun A; Osman M; Awadalla S; Klein LW
    Am J Cardiol; 2020 Dec; 137():83-88. PubMed ID: 32991856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease.
    McInerney A; García Márquez M; Tirado-Conte G; Bernal JL; Fernández-Pérez C; Jiménez-Quevedo P; Gonzalo N; Núñez-Gil I; Del Prado N; Escaned J; Fernández-Ortiz A; Elola J; Nombela-Franco L
    Rev Esp Cardiol (Engl Ed); 2023 Aug; 76(8):600-608. PubMed ID: 36669732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of delayed coronary artery access for coronary angiography with or without percutaneous coronary intervention (PCI) in patients who underwent transcatheter aortic valve replacement (TAVR).
    Diaz MA; Patton M; Valdes P; Vieira JL; Rmeileh A; Macedo FY
    Cardiovasc Interv Ther; 2022 Jan; 37(1):167-181. PubMed ID: 33453034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Fischer J; Steffen J; Arlart T; Haum M; Gschwendtner S; Doldi PM; Rizas K; Theiss H; Braun D; Orban M; Peterß S; Hausleiter J; Massberg S; Deseive S
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):186-193. PubMed ID: 38140761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
    Maeno Y; Abramowitz Y; Kawamori H; Kazuno Y; Kubo S; Takahashi N; Mangat G; Okuyama K; Kashif M; Chakravarty T; Nakamura M; Cheng W; Friedman J; Berman D; Makkar RR; Jilaihawi H
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1139-1147. PubMed ID: 28412434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement.
    van den Boogert TPW; Vendrik J; Gunster JLB; van Mourik MS; Claessen BEPM; van Kesteren F; Koch KT; Wykrzykowska JJ; Vis MM; Winkelman TA; Driessen AHG; Beijk MAM; de Winter RJ; Tijssen JGP; Planken NR; Baan J; Henriques JP
    J Invasive Cardiol; 2021 Oct; 33(10):E823-E832. PubMed ID: 34609327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes of Transcatheter Aortic Valve Replacement With and Without Percutaneous Coronary Intervention-An Updated Meta-Analysis and Systematic Review.
    Yassen M; Moustafa A; Venkataramany B; Schodowski E; Royfman R; Eltahawy E
    Curr Probl Cardiol; 2023 Nov; 48(11):101980. PubMed ID: 37473936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Massussi M; Adamo M; Rosati F; Chizzola G; Metra M; Tarantini G
    Catheter Cardiovasc Interv; 2023 May; 101(6):1154-1160. PubMed ID: 36994903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Kaihara T; Higuma T; Izumo M; Kotoku N; Suzuki T; Kameshima H; Sato Y; Kuwata S; Koga M; Mitarai T; Watanabe M; Okuyama K; Kamijima R; Ishibashi Y; Yoneyama K; Tanabe Y; Harada T; Akashi YJ
    Clin Cardiol; 2021 Aug; 44(8):1089-1097. PubMed ID: 34033124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.
    Maes F; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto W; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Salah-Annabi M; Pelletier-Beaumont E; Côté M; Puri R; Pibarot P; Rodés-Cabau J
    JAMA Cardiol; 2019 Jan; 4(1):64-70. PubMed ID: 30566185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
    Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
    Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.